Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms” - Publication - Bridge of Knowledge

Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms”

Abstract

Citations

1

CrossRef
0

Web of Science
1

Scopus

Authors (13)

Eleftherios Chatzellis
Kosmas Daskalakis
Anna Angelousi
Marina Tsoli
Krystallenia I. Alexandraki
Ewa Wachula
Amichay Meirovitz
Ofra Maimon
Simona Grozinsky-Glasberg
David Gross
Beata Kos-Kudła
Anna Koumarianou
Gregory Kaltsas

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: NEUROENDOCRINOLOGY no. 110, edition 1-2, pages 158 - 160,
ISSN: 0028-3835
ISSN:: 0028-3835
Publication year:: 2020
DOI:: Digital Object Identifier (open in new tab) 10.1159/000503999
Verified by:: No verification

seen 45 times